Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Nestle and Danone encounter regulatory pressure amid infant formula contamination updates

20/05/2026 Published by vivi

Global food manufacturing giants Nestle and Danone are navigating intense public and regulatory scrutiny following coordinated investigative reports published by... Read more

Tags: #Global Trends

Global Healthcare Opportunities and CBC Group align to forge world’s largest healthcare investment entity

20/05/2026 Published by vivi

One of Europe’s premier healthcare-focused private equity firms, Global Healthcare Opportunities (GHO), and Asia's prominent CBC Group are merging operations... Read more

Category: Uncategorized

Tags: #M&A

Mentari Therapeutics targets Nasdaq listing through strategic InMed merger

20/05/2026 Published by vivi

Privately held biotechnology innovator Mentari Therapeutics has entered into a definitive, all-stock merger agreement with InMed Pharmaceuticals (NASDAQ: INM). The... Read more

Category: Uncategorized

Tags: #Global Trends

Pillr Health acquires CaptureRx to expand its federal pharmacy infrastructure footprint

20/05/2026 Published by vivi

Pillr Health has finalized the acquisition of San Antonio-based administrative specialist CaptureRx, effectively broadening its operational scale and federal 340B... Read more

Category: Uncategorized

Tags: #M&A

Regeneron enters multi-billion dollar alliance with Parabilis to develop novel peptide platform

20/05/2026 Published by vivi

Regeneron Pharmaceuticals has finalized a comprehensive research and development collaboration valued at $2.32 billion with Parabilis Medicines. The joint initiative... Read more

Category: Uncategorized

Tags: #Global Trends

BioMarin’s acquired rare disease candidate falls short of clinical trial efficacy target

20/05/2026 Published by vivi

An investigational therapeutic agent acquired by BioMarin Pharmaceutical via a corporate buyout has failed to meet one of its two... Read more

Category: Uncategorized

Tags: #Global Trends

Migraine therapeutics developer targets public market debut via reverse merger

20/05/2026 Published by vivi

Privately held biopharmaceutical firm Mentari Therapeutics has unveiled plans to transition into the public equity markets through a definitive reverse... Read more

Category: Uncategorized

Tags: #Global Trends

Positive milestones achieved in clinical evaluation of novel vascular disorder therapy

20/05/2026 Published by vivi

An investigational drug candidate developed by Relay Therapeutics has demonstrated encouraging efficacy signals in a mid-stage clinical trial, presenting a... Read more

Category: Uncategorized

Tags: #Global Trends

Pharmaceutical manufacturer penalised hundreds of millions over market delay agreement

20/05/2026 Published by vivi

A federal jury in Boston has delivered a milestone antitrust verdict against Takeda, finding the Japanese drugmaker liable for conspiring... Read more

Category: Uncategorized

Tags: #Global Trends

Posts pagination

Previous page Page 1 … Page 29 Page 30 Page 31 … Page 157 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members